文献速递瓣膜外科

机器人辅助经导管主动脉瓣取出与主动脉瓣置换术

Robotic-Assisted Transcatheter Aortic Valve Explantation and Aortic Valve Replacement.
PubMed 文献 · Ann Thorac Surg · 2025-07-31

本文报告一例67岁女性患者,既往低危接受23 mm球囊扩张式TAVR,4年后出现严重人工主动脉瓣狭窄、射血分数降至35%、重度III型二尖瓣反流及症状性心衰。在获得知情同意后,经右侧腋窝工作切口行机器人辅助TAVR取出,并置换21 mm生物瓣主动脉瓣,同期行二尖瓣置换,总主动脉阻断时间195分钟,患者顺利出院。结论认为机器人TAVR取出和主动脉瓣置换可行,可能成为低至中危患者的未来选择。

要点

  • 年轻患者TAVR后可能因瓣膜提前衰败需行外科取出。
  • 机器人辅助经腋窝切口可行TAVR取出并同期双瓣置换。
  • 该术式可能适用于低至中危外科风险患者。

核心结论

  • 机器人TAVR取出和主动脉瓣置换可行,可能成为低至中危手术风险患者的未来选择。

研究设计与样本

  • 病例报告:一例67岁女性,既往低危接受23 mm球囊扩张式TAVR,4年后因严重人工主动脉瓣狭窄等行机器人辅助TAVR取出及双瓣置换。

主要发现

  • 患者术前射血分数降至35%,伴重度III型二尖瓣反流和症状性心衰。
  • 手术经右侧腋窝工作切口完成机器人TAVR取出,并置换21 mm生物瓣主动脉瓣,同期行二尖瓣置换。
  • 总主动脉阻断时间为195分钟,患者顺利出院。

关键数值与推荐

  • 患者STS预测死亡风险为7.9%。
  • TAVR瓣膜为23 mm球囊扩张式,植入时评为低危,4年后出现严重结构性瓣膜衰败。

临床怎么用

  • 对于年轻、TAVR后瓣膜衰败且需双瓣置换的患者,可考虑机器人辅助非胸骨切开途径行TAVR取出和外科瓣膜置换。

局限性

  • 本文为单例病例报告,结论的普遍适用性需进一步研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Transcatheter aortic valve replacement (TAVR) in younger patients may be complicated by premature structural valve degeneration. This report describes robotic TAVR explantation and aortic valve replacement. DESCRIPTION: A 67-year-old woman who underwent low-risk, 23-mm balloon-expandable TAVR 4 years previously presented with severe prosthetic aortic stenosis, a drop in ejection fraction to 35%, severe type III mitral regurgitation, and symptomatic heart failure. She had scoliosis and rheumatoid arthritis, and The Society of Thoracic Surgeons predicted risk of mortality was 7.9%. Given her younger age and need for double valve replacement, transcatheter options were deferred, and she was referred for intermediate- to high-risk nonsternotomy surgical consideration. EVALUATION: After obtaining informed consent, a right lateral transaxillary working incision facilitated robotic TAVR explantation, followed by 21-mm bioprosthetic aortic valve replacement with concomitant mitral valve replacement. The total cross-clamp time was 195 minutes. The patient recovered expectantly and was discharged home. CONCLUSIONS: Robotic TAVR explantation and aortic valve replacement are feasible and may represent a viable future option for patients of low to intermediate surgical risk.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Badhwar V, Darehzereshki A, Raikar GV, et al. Robotic-Assisted Transcatheter Aortic Valve Explantation and Aortic Valve Replacement. Ann Thorac Surg. 2025. PMID: 40750037. doi:10.1016/j.athoracsur.2025.07.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。